Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Alemtuzumab for Patients With Chronic Lymphocytic Leukaemia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434436/0/Hysterectomy_versus_hysterectomy_plus_oophorectomy_for_premenopausal_women_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed 19 April 2024.
Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434436/0/Hysterectomy_versus_hysterectomy_plus_oophorectomy_for_premenopausal_women_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed April 19, 2024.
Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434436/0/Hysterectomy_versus_hysterectomy_plus_oophorectomy_for_premenopausal_women_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
Alemtuzumab for Patients With Chronic Lymphocytic Leukaemia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434436/0/Hysterectomy_versus_hysterectomy_plus_oophorectomy_for_premenopausal_women_Stable__no_update_expected_for_reasons_given_in_'What's_new'_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review
ID - 434436
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434436/0/Hysterectomy_versus_hysterectomy_plus_oophorectomy_for_premenopausal_women_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
DB - Evidence Central
DP - Unbound Medicine
ER -